Premera Blue Cross Responds to Conduent Data Security Incident
This notice concerns a data security incident that occurred at Conduent and involved some Premera Blue Cross member information. This incident did not involve Premera's IT systems.
On
The investigation determined that an unauthorized third party accessed Conduent's environment from
The personal information contained in the affected files may have included names, Social Security numbers, dates of birth, treatment/diagnosis description or code, treatment cost, date of admission/discharge, member identification number and/or claim number. Not every data element was present for every individual.
Premera sincerely regrets any concern this incident may cause its members. According to Conduent, upon discovering the incident, it secured its network, notified law enforcement authorities, and safely restored its systems and operations.
Letters are being mailed to individuals whose information was contained in the affected files, including an offer of complimentary credit monitoring and identity protection services for two years. In addition, Conduent posted notice of this incident on its website, https://www.conduent.com/notice-2912609/ and has established a dedicated call center to answer your questions.
If you have questions regarding this incident or believe you are an affected individual who did not receive a notification letter, please call 855-291-2609 (toll-free), Monday‒Friday, from
About Premera Blue Cross
Premera Blue Cross, a not-for-profit, independent licensee of the Blue Cross Blue Shield Association based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/premera-blue-cross-responds-to-conduent-data-security-incident-302592987.html
SOURCE Premera Blue Cross
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seekr Recognized on Fast Company's 2026 Next Big Things in Tech List
- Cedar Investment Group Launches to Originate, Finance, and Deliver Compute Capacity at the Cutting Edge of U.S. Digital Infrastructure
- TranspireBio Announces Successful Completion of a Pivotal Phase 1 Study with its Proprietary Springboard™ Soft Mist Inhaler Platform
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share